
Reset all filters
01 2AbbVie Inc
02 3Aspen Pharmacare Holdings
03 2Alembic Pharmaceuticals Limited
04 2Apotex Inc
05 2Aristo Pharma GmbH
06 2Aurobindo Pharma Limited
07 2Cipla
08 2Cps Cito Pharma Services Gmbh
09 2Inventia Healthcare Limited
10 2JAMP PHARMA
11 2Jubilant Generics
12 6Macleods Pharmaceuticals Limited
13 6Merus Labs Luxco S. à R. L.
14 2PH HEALTH
15 2PolyGen Pharmaceuticals
16 2SEARCHLIGHT PHARMA
17 2Torrent Pharmaceuticals Limited
18 2Xiromed
19 2pharma&
20 8Blank
Reset all filters
01 6Depot tablet
02 2ER TABLET
03 8ER Tablet
04 2Extended Release Tablet
05 2Extended-Release Tablet
06 2Modified Release Tablet
07 2SRT
08 3TAB
09 6TABLET (EXTENDED-RELEASE)
10 20TABLET, EXTENDED RELEASE;ORAL
11 2Tablet
Reset all filters
01 2Allowed
02 2Approved
03 2Authorized
04 2Countries Registered In: US (Filed 2013)
05 8DISCN
06 2Generic
07 2Generic US CTD
08 3Originator
09 6Prescription
10 12RX
11 6Registered in US
12 2US (Filed 2013)
13 6Blank
Reset all filters
01 2APO-DARIFENACIN
02 2DARIFENACIN
03 16DARIFENACIN HYDROBROMIDE
04 2Darifenacina Aristo
05 4ENABLEX
06 10Emselex
07 1Enablex 15mg
08 2Enablex 7,5mg
09 1Floden CR 15 mg
10 1Floden CR 7.5 mg
11 2JAMP DARIFENACIN
12 12Blank
Reset all filters
01 6Canada
02 8India
03 6Norway
04 5South Africa
05 2Spain
06 2Sweden
07 2Switzerland
08 20USA
09 2United Kingdom
10 2Blank
Regulatory Info : DISCN
Registration Country : USA
Brand Name : ENABLEX
Dosage Form : TABLET, EXTENDED RELEASE;ORAL
Dosage Strength : EQ 7.5MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Packaging :
Approval Date : 2004-12-22
Application Number : 21513
Regulatory Info : DISCN
Registration Country : USA
Regulatory Info : Originator
Registration Country : South Africa
Brand Name : Enablex 7,5mg
Dosage Form : TAB
Dosage Strength : 7.5mg
Packaging : 28X1mg
Approval Date :
Application Number :
Regulatory Info : Originator
Registration Country : South Africa
Regulatory Info : DISCN
Registration Country : USA
Brand Name : ENABLEX
Dosage Form : TABLET, EXTENDED RELEASE;ORAL
Dosage Strength : EQ 15MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Packaging :
Approval Date : 2004-12-22
Application Number : 21513
Regulatory Info : DISCN
Registration Country : USA
Regulatory Info : Originator
Registration Country : South Africa
Brand Name : Enablex 7,5mg
Dosage Form : TAB
Dosage Strength : 7.5mg
Packaging : 14X1mg
Approval Date :
Application Number :
Regulatory Info : Originator
Registration Country : South Africa
Regulatory Info : Originator
Registration Country : South Africa
Brand Name : Enablex 15mg
Dosage Form : TAB
Dosage Strength : 15mg
Packaging : 28X1mg
Approval Date :
Application Number :
Regulatory Info : Originator
Registration Country : South Africa
Regulatory Info : RX
Registration Country : USA
Brand Name : DARIFENACIN HYDROBROMIDE
Dosage Form : TABLET, EXTENDED RELEASE;ORAL
Dosage Strength : EQ 7.5MG BASE
Packaging :
Approval Date : 2017-12-08
Application Number : 207681
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : DARIFENACIN HYDROBROMIDE
Dosage Form : TABLET, EXTENDED RELEASE;ORAL
Dosage Strength : EQ 15MG BASE
Packaging :
Approval Date : 2017-12-08
Application Number : 207681
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : DARIFENACIN HYDROBROMIDE
Dosage Form : TABLET, EXTENDED RELEASE;ORAL
Dosage Strength : EQ 7.5MG BASE
Packaging :
Approval Date : 2016-09-19
Application Number : 206743
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : DARIFENACIN HYDROBROMIDE
Dosage Form : TABLET, EXTENDED RELEASE;ORAL
Dosage Strength : EQ 15MG BASE
Packaging :
Approval Date : 2016-09-19
Application Number : 206743
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : DARIFENACIN HYDROBROMIDE
Dosage Form : TABLET, EXTENDED RELEASE;ORAL
Dosage Strength : EQ 7.5MG BASE
Packaging :
Approval Date : 2016-09-01
Application Number : 207664
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : DARIFENACIN HYDROBROMIDE
Dosage Form : TABLET, EXTENDED RELEASE;ORAL
Dosage Strength : EQ 15MG BASE
Packaging :
Approval Date : 2016-09-01
Application Number : 207664
Regulatory Info : RX
Registration Country : USA
Regulatory Info : DISCN
Registration Country : USA
Brand Name : DARIFENACIN HYDROBROMIDE
Dosage Form : TABLET, EXTENDED RELEASE;ORAL
Dosage Strength : EQ 7.5MG BASE
Packaging :
Approval Date : 2016-10-12
Application Number : 205550
Regulatory Info : DISCN
Registration Country : USA
Regulatory Info : DISCN
Registration Country : USA
Brand Name : DARIFENACIN HYDROBROMIDE
Dosage Form : TABLET, EXTENDED RELEASE;ORAL
Dosage Strength : EQ 15MG BASE
Packaging :
Approval Date : 2016-10-12
Application Number : 205550
Regulatory Info : DISCN
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : DARIFENACIN
Dosage Form : TABLET, EXTENDED RELEASE;ORAL
Dosage Strength : EQ 7.5MG BASE
Packaging :
Approval Date : 2017-07-28
Application Number : 207302
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : DARIFENACIN
Dosage Form : TABLET, EXTENDED RELEASE;ORAL
Dosage Strength : EQ 15MG BASE
Packaging :
Approval Date : 2017-07-28
Application Number : 207302
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : DARIFENACIN HYDROBROMIDE
Dosage Form : TABLET, EXTENDED RELEASE;ORAL
Dosage Strength : EQ 7.5MG BASE
Packaging :
Approval Date : 2016-11-17
Application Number : 205209
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : DARIFENACIN HYDROBROMIDE
Dosage Form : TABLET, EXTENDED RELEASE;ORAL
Dosage Strength : EQ 15MG BASE
Packaging :
Approval Date : 2016-11-17
Application Number : 205209
Regulatory Info : RX
Registration Country : USA
Regulatory Info : DISCN
Registration Country : USA
Brand Name : DARIFENACIN HYDROBROMIDE
Dosage Form : TABLET, EXTENDED RELEASE;ORAL
Dosage Strength : EQ 15MG BASE
Packaging :
Approval Date : 2019-10-22
Application Number : 209571
Regulatory Info : DISCN
Registration Country : USA
Regulatory Info : DISCN
Registration Country : USA
Brand Name : DARIFENACIN HYDROBROMIDE
Dosage Form : TABLET, EXTENDED RELEASE;ORAL
Dosage Strength : EQ 7.5MG BASE
Packaging :
Approval Date : 2015-03-13
Application Number : 91190
Regulatory Info : DISCN
Registration Country : USA
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
Regulatory Info : DISCN
Registration Country : USA
Brand Name : DARIFENACIN HYDROBROMIDE
Dosage Form : TABLET, EXTENDED RELEASE;ORAL
Dosage Strength : EQ 15MG BASE
Packaging :
Approval Date : 2015-03-13
Application Number : 91190
Regulatory Info : DISCN
Registration Country : USA
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF